Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...

Oppenheimer 35th Annual Healthcare Life Sciences Conference Presentation Date: Tuesday, February 11, 2025 at 2:40 PM ET Presentation Format: Corporate Presentation Webcast: ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...

The Minnesota Twins face a crucial offseason decision regarding utilityman Willi Castro. Arbitration projects him to earn $6.4 million in 2025, which impacts the team’s payroll flexibility.

Colette Love makes the Radio 4 Appeal on behalf of the Prader-Willi Syndrome Association UK. The charity runs a phone line for families affected by the condition. Show more Colette Love makes the ...

“The Rett syndrome community in Europe is excited by the prospect of having an available treatment option. Rett syndrome has a significant impact on people living with this condition, and also ...